Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Shares Issued (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Shares Issued for 3 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.2 million, a N/A change, with the full-year FY2024 number at $4.4 million, changed N/A from a year prior.
  • Shares Issued was $2.0 million for Q3 2025 at bioAffinity Technologies, up from $1.6 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.0 million in Q3 2025 to a low of $74899.0 in Q1 2024.
  • A 3-year average of $1.4 million and a median of $1.6 million in 2025 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 1463.66% in 2025; the steepest drop was 15.69% in 2025.
  • bioAffinity Technologies' Shares Issued stood at $1.7 million in 2022, then dropped by 16.91% to $1.4 million in 2024, then skyrocketed by 43.87% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Shares Issued are $2.0 million (Q3 2025), $1.6 million (Q2 2025), and $1.2 million (Q1 2025).